| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |